Cargando…

Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus

Exosomes have been proposed as candidates for therapeutic immunization. The present study demonstrates that incorporation of the G protein of vesicular stomatitis virus (VSV-G) into exosome-like vesicles (ELVs) enhances their uptake and induces the maturation of dendritic cells. Targeting of VSV-G a...

Descripción completa

Detalles Bibliográficos
Autores principales: Temchura, Vladimir V., Tenbusch, Matthias, Nchinda, Godwin, Nabi, Ghulam, Tippler, Bettina, Zelenyuk, Maryna, Wildner, Oliver, Überla, Klaus, Kuate, Seraphin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115564/
https://www.ncbi.nlm.nih.gov/pubmed/18538453
http://dx.doi.org/10.1016/j.vaccine.2008.04.069
_version_ 1783514124411469824
author Temchura, Vladimir V.
Tenbusch, Matthias
Nchinda, Godwin
Nabi, Ghulam
Tippler, Bettina
Zelenyuk, Maryna
Wildner, Oliver
Überla, Klaus
Kuate, Seraphin
author_facet Temchura, Vladimir V.
Tenbusch, Matthias
Nchinda, Godwin
Nabi, Ghulam
Tippler, Bettina
Zelenyuk, Maryna
Wildner, Oliver
Überla, Klaus
Kuate, Seraphin
author_sort Temchura, Vladimir V.
collection PubMed
description Exosomes have been proposed as candidates for therapeutic immunization. The present study demonstrates that incorporation of the G protein of vesicular stomatitis virus (VSV-G) into exosome-like vesicles (ELVs) enhances their uptake and induces the maturation of dendritic cells. Targeting of VSV-G and ovalbumin as a model antigen to the same ELVs increased the cross-presentation of ovalbumin via an endosomal acidification mechanism. Immunization of mice with VSV-G and ovalbumin containing ELVs led to an increased IgG2a antibody response, expansion of antigen-specific CD8 T cells, strong in vivo CTL responses, and protection from challenge with ovalbumin expressing tumor cells. Thus, incorporation of VSV-G and targeting of antigens to ELVs are attractive strategies to improve exosomal vaccines.
format Online
Article
Text
id pubmed-7115564
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71155642020-04-02 Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus Temchura, Vladimir V. Tenbusch, Matthias Nchinda, Godwin Nabi, Ghulam Tippler, Bettina Zelenyuk, Maryna Wildner, Oliver Überla, Klaus Kuate, Seraphin Vaccine Article Exosomes have been proposed as candidates for therapeutic immunization. The present study demonstrates that incorporation of the G protein of vesicular stomatitis virus (VSV-G) into exosome-like vesicles (ELVs) enhances their uptake and induces the maturation of dendritic cells. Targeting of VSV-G and ovalbumin as a model antigen to the same ELVs increased the cross-presentation of ovalbumin via an endosomal acidification mechanism. Immunization of mice with VSV-G and ovalbumin containing ELVs led to an increased IgG2a antibody response, expansion of antigen-specific CD8 T cells, strong in vivo CTL responses, and protection from challenge with ovalbumin expressing tumor cells. Thus, incorporation of VSV-G and targeting of antigens to ELVs are attractive strategies to improve exosomal vaccines. Elsevier Ltd. 2008-07-04 2008-05-16 /pmc/articles/PMC7115564/ /pubmed/18538453 http://dx.doi.org/10.1016/j.vaccine.2008.04.069 Text en Copyright © 2008 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Temchura, Vladimir V.
Tenbusch, Matthias
Nchinda, Godwin
Nabi, Ghulam
Tippler, Bettina
Zelenyuk, Maryna
Wildner, Oliver
Überla, Klaus
Kuate, Seraphin
Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus
title Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus
title_full Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus
title_fullStr Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus
title_full_unstemmed Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus
title_short Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus
title_sort enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent g protein of vesicular stomatitis virus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115564/
https://www.ncbi.nlm.nih.gov/pubmed/18538453
http://dx.doi.org/10.1016/j.vaccine.2008.04.069
work_keys_str_mv AT temchuravladimirv enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus
AT tenbuschmatthias enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus
AT nchindagodwin enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus
AT nabighulam enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus
AT tipplerbettina enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus
AT zelenyukmaryna enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus
AT wildneroliver enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus
AT uberlaklaus enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus
AT kuateseraphin enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus